Journal Article Summary
The article investigates the effectiveness and safety of combining ciclosporin A (CSA) with methotrexate (MTX) for treating patients with active psoriatic arthritis (PsA) who have not fully responded to MTX alone. PsA is a chronic inflammatory condition that can lead to joint damage and significantly affect a person's quality of life. Understanding how to enhance treatment for patients who do not respond adequately to standard therapies is crucial for improving outcomes in this population.
In this study, 72 patients with active PsA and an incomplete response to MTX were randomly assigned to receive either CSA or a placebo over 12 months. The researchers conducted thorough clinical assessments and used high-resolution ultrasound to evaluate joint inflammation. The results showed that while both groups experienced some improvements, those receiving CSA had a notable reduction in swollen joint counts, indicating a decrease in inflammation. However, there were no significant changes in pain levels or overall quality of life for patients in either group.
The study has some limitations, including a relatively small sample size and a focus on short-term outcomes. Patients should be aware that while combining CSA with MTX may help reduce inflammation, it does not necessarily alleviate pain or improve quality of life. It is important for individuals with PsA to discuss their treatment options and any concerns with their healthcare provider to ensure they receive the most appropriate care tailored to their needs.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Fraser A, van Kuijk A W R, Westhovens R, Karim Z, Wakefield R, Gerards A, Landewe R, Steinfeld S, et al.. A randomised, double blind, placebo controlled, multicentre trial of combination therapy with methotrexate plus ciclosporin in patients with active psoriatic arthritis. Annals of the Rheumatic Diseases 2005. DOI: 10.1136/ard.2004.024463. PMID: 15528283. PMCID: PMC1755527.
Featured Pill Pals Product
Cyclosporine Eye Drops 0.05% --- 0.4 ML --- Pack of 30 --- Generic For Restasis --- Apotex
Cyclosporine Eye Drops 0.05% — 0.4 ML — Pack of 30 — Generic For Restasis — Apotex is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
